Showing results (1-10 of 115) with videos related to

Sort By:
Pageof 12
Cardiology|October 4, 2022
The Obesity Paradox in Heart Failure: Is It Still Valid in Light of New Therapies?Hanna Fröhlich, Norbert Frey, Lutz Frankenstein, et al.
Revista Espanola De Cardiologia (English Ed.)|September 28, 2015
Multidisciplinary Approach for Patients Hospitalized With Heart FailureLutz Frankenstein, Hanna Fröhlich, John G F Cleland
Cardiovascular Therapeutics|May 24, 2011
Influence of sex on treatment and outcome in chronic heart failureLutz Frankenstein, Andrew L Clark, Jorge P Ribeiro
European Heart Journal. Quality of Care & Clinical Outcomes|June 2, 2026
Affordability of Innovation -Cost-effectiveness and Budget Impact Analysis of Acoramidis in Transthyretin Amyloid Cardiomyopathy in the German Health-care SystemBent Estler, Hanna Fröhlich, Tobias Täger, et al.
Therapeutische Umschau. Revue Therapeutique|September 30, 2008
[Chronic systolic heart failure - dosing recommendations at beginning and end of treatment]Christian Zugck, Andrew Remppis, Hugo A Katus, et al.
Journal of Medical Economics|November 25, 2020
An analysis of the cost-effectiveness of transcatheter mitral valve repair for people with secondary mitral valve regurgitation in the UKJudith Shore, Joel Russell, Lutz Frankenstein, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|January 5, 2023
Prognostic relevance of gradual weight changes on long-term mortality in chronic heart failureTobias Täger, Jennifer Franke, Norbert Frey, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|November 25, 2025
Cost-effectiveness and budget-impact analysis of Acetazolamide in decompensated heart failure patients with volume overload in the German health care systemBent Estler, Hanna Fröhlich, Tobias Täger, et al.
Current Heart Failure Reports|June 3, 2009
Respiratory muscle function and exercise intolerance in heart failureJorge P Ribeiro, Gaspar R Chiappa, J Alberto Neder, et al.
Pageof 12